Rigel Pharmaceuticals (RIGL) Earnings Date, Estimates & Call Transcripts $19.91 -0.52 (-2.55%) Closing price 04:00 PM EasternExtended Trading$19.92 +0.01 (+0.05%) As of 05:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Rigel Pharmaceuticals Latest Earnings SummaryUpcoming Q1 Earnings DateMay. 6After Market ClosesEstimatedActual EPS (Mar. 4) $0.80 Beat By $0.50 Consensus EPS (Mar. 4) $0.30 Rigel Pharmaceuticals announced Q4 2024 earnings on March 4, 2025, reporting an EPS of $0.80, which beat analysts' consensus estimates of $0.30 by $0.50. Quarterly revenue was reported to be $57.60 million, above analyst estimates of $57.59 million. With a trailing EPS of $0.94 and a P/E Ratio of 142.22, Rigel Pharmaceuticals' earnings are expected to grow 377.27% next year, from $0.22 to $1.05 per share. Conference CallConference Call TranscriptEarnings Press ReleaseEarnings Slide DeckPowered by RIGL Upcoming EarningsRigel Pharmaceuticals' next earnings date is estimated for Tuesday, May 6, 2025, based off prior year's reporting schedules. Get Rigel Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Rigel Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataRIGL Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.RIGL Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Remove Ads Rigel Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.07$0.10$0.02Q2 20252$0.12$0.18$0.15Q3 20252$0.17$0.34$0.26Q4 20252$0.38$0.48$0.43FY 20258$0.60$1.10$0.85 Remove Ads Rigel Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/6/2025(Estimated)-------3/4/2025Q4 2024$0.30$0.80+$0.50$0.80$57.59M$57.60M11/7/2024Q3 2024$0.0080$0.70+$0.6920$0.70$40.69M$55.31M8/6/2024Q2 2024-$0.37-$0.06+$0.31-$0.06$32.38M$36.84M5/7/2024Q1 2024-$0.30-$0.50 -$0.20-$0.05$31.28M$29.53M11/7/2023Q3 2023-$0.70-$0.30+$0.40-$0.03$27.83M$28.13M8/1/2023Q2 2023-$0.80-$0.40+$0.40-$0.04$26.02M$26.89M5/2/2023Q1 2023-$0.90-$0.80+$0.10-$0.08$24.29M$26.07M Rigel Pharmaceuticals Earnings - Frequently Asked Questions When is Rigel Pharmaceuticals's earnings date? Rigel Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 6th, 2025 based off last year's report dates. Learn more on RIGL's earnings history. What guidance has Rigel Pharmaceuticals issued on next quarter's earnings? Rigel Pharmaceuticals updated its FY 2025 earnings guidance on Tuesday, March, 4th. The company issued revenue guidance of $200.0 million-$210.0 million, compared to the consensus revenue estimate of $204.9 million. Did Rigel Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Rigel Pharmaceuticals (NASDAQ:RIGL) reported $0.80 earnings per share (EPS) to beat the analysts' consensus estimate of $0.30 by $0.50. Learn more on analysts' earnings estimate vs. RIGL's actual earnings. How can I listen to Rigel Pharmaceuticals's earnings conference call? The conference call for Rigel Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Rigel Pharmaceuticals's conference call transcript? The conference call transcript for Rigel Pharmaceuticals's latest earnings report can be read online. Read Transcript How much revenue does Rigel Pharmaceuticals generate each year? Rigel Pharmaceuticals (NASDAQ:RIGL) has a recorded annual revenue of $179.28 million. How much profit does Rigel Pharmaceuticals generate each year? Rigel Pharmaceuticals (NASDAQ:RIGL) has a recorded net income of -$25.09 million. RIGL has generated $0.94 earnings per share over the last four quarters. What is Rigel Pharmaceuticals's price-to-earnings ratio? Rigel Pharmaceuticals (NASDAQ:RIGL) has a trailing price-to-earnings ratio of 143.19 and a forward price-to-earnings ratio of 91.11. What is Rigel Pharmaceuticals's EPS forecast for next year? Rigel Pharmaceuticals's earnings are expected to grow from $0.22 per share to $1.05 per share in the next year, which is a 377.27% increase. More Earnings Resources from MarketBeat Related Companies Celldex Therapeutics Earnings Date Novavax Earnings Date OPKO Health Earnings Date Innoviva Earnings Date Geron Earnings Date Myriad Genetics Earnings Date Verastem Earnings Date Emergent BioSolutions Earnings Date Vanda Pharmaceuticals Earnings Date XOMA Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles These 3 Q1 Earnings Winners Will Go HigherAnalysts Lift Archer Aviation Stock Despite Earnings Miss DigitalOcean Rides Cloud Wave and AI Hype to Strong EarningsPrice Targets on NVIDIA Rise in Front of EarningsThe Trade Desk Crashes on Earnings, But Growth Catalysts PersistHims & Hers Earnings Could Be a Game Changer—What to Do NowAnalysts See Buying Opportunity in NVIDIA Before Earnings Remove Ads This page (NASDAQ:RIGL) was last updated on 3/13/2025 by MarketBeat.com Staff From Our PartnersElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredYour Wealth is Under AttackHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rigel Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rigel Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
